Evidence map›Paper›PMID 23429341›Full record

ArticleEMBO reports2013

Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway.

Irmina Diala, Nicole Wagner, Frédérique Magdinier, Marina Shkreli, Maria Sirakov, Serge Bauwens, Caroline Schluth-Bolard, Thomas Simonet, Valérie M Renault, Jing Ye and 7 more

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Telomere Targeting Approaches in Cancer: Beyond Length Maintenance.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Non-canonical roles of canonical telomere binding proteins in cancers.Cellular and molecular life sciences : CMLS · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Telomere-related Markers for Cancer.Current topics in medicinal chemistry · 2020
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Irmina DialaFaculté de Médecine de Nice, Institut for Research on Cancer and Aging, Nice (IRCAN), Nice University, Nice, France.
Nicole Wagner
Frédérique Magdinier
Marina Shkreli
Maria Sirakov
Serge Bauwens
Caroline Schluth-Bolard
Thomas Simonet
Valérie M Renault
Jing Ye
Abdelnnadir Djerbi
Pascal Pineau
Jinkuk Choi
Steven Artandi
Anne Dejean
Michelina Plateroti
Eric Gilson
École Normale Supérieure de Lyon · FRInserm · FRCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRStanford University · USInstitut Pasteur · FR

Funding

Wnt signaling in muscle stem cell agingP01AG036695 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARGARET A. GOODELL · 2011 to 2026
$29.3M
NIA NIH HHS P01 AG036695
6 · The paper itself

Abstract

The DNA-binding protein TRF2 is essential for telomere protection and chromosome stability in mammals. We show here that TRF2 expression is activated by the Wnt/β-catenin signalling pathway in human cancer and normal cells as well as in mouse intestinal tissues. Furthermore, β-catenin binds to TRF2 gene regulatory regions that are functional in a luciferase transactivating assay. Reduced β-catenin expression in cancer cells triggers a marked increase in telomere dysfunction, which can be reversed by TRF2 overexpression. We conclude that the Wnt/β-catenin signalling pathway maintains a level of TRF2 critical for telomere protection. This is expected to have an important role during development, adult stem cell function and oncogenesis.

Indexed as

Gene Expression RegulationTelomere HomeostasisWnt Signaling PathwayAnimalsbeta CateninBinding SitesFemaleGene ExpressionHCT116 CellsHumansMaleMiceMice, KnockoutOligonucleotide Array Sequence AnalysisProtein BindingRNA, Messengerbeta CateninCTNNB1 protein, humanRNA, MessengerTelomeric Repeat Binding Protein 2TERF2 protein, human

Identifiers

PMID23429341
PMCPMC3615653
OpenAlexW2046816202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.